Livingstone Health’s strategy rooted in patient care and steady growth
The Catalist-listed group is prioritising quality over rapid expansion
[SINGAPORE] Livingstone Health is not in a rush to grow.
Much like the lithops – a hardy succulent also known as a living stone, from which the company takes its name – the Singapore-based healthcare group is taking a slow and steady approach to expansion.
The Catalist-listed company, which went public in 2021, operates 20 clinics in the Republic, staffed by 22 medical specialists and practitioners. It also runs a health-screening centre, two medical aesthetics clinics, a podiatry clinic, and provides healthcare consultancy services within the region.
TRENDING NOW
Three Holland Village shophouses sold for S$70 million to Tat Lee Bank’s Goh family unit
Palm oil stocks set to surge as Indonesia said to be scaling back export overhaul: analysts
Frasers Centrepoint Trust to sell White Sands mall for S$467 million
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan